Medigen Biotechnology (ROCO:3176) Price-to-Operating-Cash-Flow : (As of Jun. 06, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Medigen Biotechnology Price-to-Operating-Cash-Flow?

As of today (2024-06-06), Medigen Biotechnology's share price is NT$43.70. Medigen Biotechnology's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-3.80. Hence, Medigen Biotechnology's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Medigen Biotechnology's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Medigen Biotechnology's highest Price-to-Operating-Cash-Flow Ratio was 395.71. The lowest was 11.02. And the median was 39.24.

ROCO:3176's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.785
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Medigen Biotechnology's Cash Flow from Operations per share for the three months ended in Mar. 2024 was NT$-0.10. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-3.80.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 9.90% per year.

During the past 13 years, Medigen Biotechnology's highest 3-Year average Operating Cash Flow per Share Growth Rate was 9.90% per year. The lowest was -101.00% per year. And the median was -23.45% per year.

Medigen Biotechnology Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Medigen Biotechnology's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigen Biotechnology Price-to-Operating-Cash-Flow Chart

Medigen Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

15.40

Medigen Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Medigen Biotechnology's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Medigen Biotechnology's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigen Biotechnology's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Biotechnology's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medigen Biotechnology's Price-to-Operating-Cash-Flow falls into.

Medigen Biotechnology Price-to-Operating-Cash-Flow Calculation

Medigen Biotechnology's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	43.70	/	-3.799
	=

Medigen Biotechnology's Share Price of today is NT$43.70.
Medigen Biotechnology's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-3.80.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Medigen Biotechnology Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medigen Biotechnology's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigen Biotechnology (ROCO:3176) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Biotechnology Corp (ROCO:3176) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yuancyu Street, 14F, Building No.3,, Nangang District, Taipei, TWN, 11560

Website

https://www.medigen.com.tw

Medigen Biotechnology Corp is a biopharmaceutical company primarily engaged in new drug development, drug discovery, molecular diagnostics, vaccine, and generic drugs. The new drug development business focuses mainly on the clinical stage of drug development and includes PI-88 MUPAFOSTAT for the treatment of liver cancer and OBP-301 treatment using adenovirus targeted to cancer cells only. Drug discovery includes the development of human-native mAbs for therapeutic applications related to infectious diseases. Generic drugs include pharmaceuticals for infectious diseases (antibiotics), contraceptives, nutrition milk powder, vitamin C tablets, dermatologic agents, and eye care products.

Medigen Biotechnology (ROCO:3176) Headlines

No Headlines